Related Experiment Video

Updated: Aug 5, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K

Biomarkers in the Era of Precision Oncology

Constantin N Baxevanis1

  • 1Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Cancers
|March 29, 2023
PubMed

Insights

Cancer heterogeneity presents a major challenge for effective cancer treatment. Understanding tumor diversity is key to developing personalized therapies for better patient outcomes.

Area of Science:

  • Oncology
  • Translational Medicine
  • Genomics

Background:

  • Cancer heterogeneity, the presence of diverse cell populations within a tumor, complicates treatment strategies.
  • Optimizing clinical protocols is hindered by the complex nature of tumor evolution and variability.

Discussion:

  • Addressing cancer heterogeneity is crucial for overcoming treatment resistance.
  • Developing adaptive therapeutic approaches is essential to manage evolving tumor cell populations.

Key Insights:

  • Tumor heterogeneity significantly impacts treatment efficacy and patient prognosis.
  • Personalized medicine strategies are needed to target diverse cancer cell subclones.

Outlook:

  • Future research should focus on novel biomarkers to track and target cancer heterogeneity.
  • Advancements in precision oncology aim to improve durable clinical responses in cancer patients.

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.9K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K